ReviewOpen Access
Antifungal resistance in dermatophytes – review of the epidemiology, diagnostic challenges and treatment strategies for managing <i>Trichophyton indotineae</i> infections
Authors
Author Affiliations
Mediprobe Research (Canada), University of Toronto, BRAC University, Ariel University, ...
Published InExpert Review of Anti-infective Therapy
Year2024
Citations28
Abstract
INTRODUCTION: infections. This species is usually poorly responsive to terbinafine. AREAS COVERED: . Terbinafine has become less effective as a first-line agent attributed to mutations in the squalene epoxidase gene (Leu393Phe, Phe397Leu). Alternative therapies include itraconazole for a longer time-period or a higher dose (200 mg/day or higher). Generally, fluconazole and griseofulvin are not effective. In some cases, especially when the area of involvement is relatively small, topical non-allylamine antifungals may be an option either as monotherapy or in combination with oral therapy. In instances when the patient relapses after apparent clinical cure then itraconazole may be considered. Good antifungal stewardship should be considered at all times. EXPERT OPINION: When both terbinafine and itraconazole are ineffective, options include off-label triazoles…
View at Publisher
BORR does not host full-text PDFs. The button above takes you to the original publisher.